A small, privately-held, and family-focused neonatology pharmaceutical company, ONY Biotech is a leader in the creation of critically important products for the treatment of premature infants. We innovate with a singular purpose: to improve outcomes for premature babies and their families. As a USA-born neonatology biotech, we take pride in the work we do delivering treatments that serve families here in the United States and around the world.
Looking for a particular ONY Biotech employee's phone or email?
The ONY Biotech annual revenue was $15.4 million in 2026.
David Verner is the COO of ONY Biotech.
31 people are employed at ONY Biotech.
ONY Biotech is based in Amherst, New York.
The NAICS codes for ONY Biotech are [541714, 54171, 54, 541, 5417].
The SIC codes for ONY Biotech are [873, 87].